PIK3CB and osteosarcoma: found that by affecting the PI3K/AKT pathway can affect E-calmodulin levels and N-calmodulin levels in osteosarcoma cells, further altering the cell viability and EMT of osteosarcoma cells (Figure 3C) (126).